Article citationsMore>>

Orkin, C., Oka, S., Philibert, P., Brinson, C., Bassa, A., Gusev, D., et al. (2021) Long-acting Cabotegravir Plus Rilpivirine for Treatment in Adults with HIV-1 Infection: 96-Week Results of the Randomised, Open-Label, Phase 3 FLAIR Study. The Lancet HIV, 8, e185-e196.
https://doi.org/10.1016/s2352-3018(20)30340-4

has been cited by the following article:

SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top